MBX

Mbx Biosciences Stock Analysis

AI Rating

Neutral
  • Quality3/10
  • Growth 2/10
  • Value 6/10
Mbx Biosciences sales and earnings growth
MBX Growth
Fair
  • Revenue Y/Y 0.00%
  • EPS Y/Y 66.82%
  • FCF Y/Y -18.63%
Mbx Biosciences gross and profit margin trends
MBX Profitability
Low
  • Gross margin 0.00%
  • EPS margin 0.00%
  • ROIC 5Y 0.00%
Mbx Biosciences net debt vs free cash flow
MBX Risk
Great
  • Debt / Equity 0.0
  • Debt / FCF 0.0
  • Interest coverage NA

Mbx Biosciences stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks